Skip to main content
SpringerLink
Log in

Fundamentals of the Hormone Treatment of Nonendocrine Disorders

  • Chapter
Clinical Endocrinology

  • 280 Accesses

Abstract

Whereas the proportion of patients with malignant growths within the total hospital population has increased considerably over the past 25 years, effective, albeit still only palliative, methods of treatment have now become available. Malignant tumors of endocrine-regulated organs (breast and prostate) are very common. When the surgical and radiotherapeutic possibilities have been exhausted, treatment with hormones is available for these cases, which are of interest to the endocrinologist as well as to the oncologist.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 74.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

The Following Works Incorporate Detailed Lists of References

  • Geller, J., Bora, R., Roberts, T., Newman, H., Lin, A., Silva, R.: Treatment of benign prostatic hypertrophy with Hydroxyprogesterone Caproate. J. Amer. med. Ass. 193, 115 (1965).

    Article  Google Scholar 

  • Griem, M.L., Jensen, E.V., Ultmann, J.E., Wissler, R.W.: Breast cancer: A challenging problem. Ree. Res. Cancer Research, No. 42. Berhn-Heidelberg-New York: Springer 1973.

    Google Scholar 

  • Marberger, H., Madersbacher, H.: Hormontherapie beim Prostatacarcinom. Verh. dtsch. Ges. inn. Med. 73, 518 (1967).

    PubMed  CAS  Google Scholar 

  • Martz, G.: Die hormonale Therapie maligner Tumoren. Heidelberger Taschenbücher No. 41. Berlin-New York-Heidelberg: Springer 1968.

    Google Scholar 

  • Nowakowski, H.: Möglichkeiten und Grenzen der endokrinen Therapie des metastasierenden Mammacarci- noms. Verh. dtsch. Ges. inn. Med. 73, 505 (1967).

    PubMed  CAS  Google Scholar 

  • Spratt,J.S., Donrgan, W. L.: Cancer of the breast. Philadelphia-London: Saunders 1967.

    Google Scholar 

  • Tausk, M.: Pharmakologie der Hormone. Stuttgart: Thieme 1970.

    Google Scholar 

  • Vernet, D.: Les gestagènes: voie nouvelle de l’hormono- thérapie dans l’hypertrophie bénigne de la prostate. Praxis 59, 1708 (1970).

    Google Scholar 

Cortisol and its Derivatives

  • Ackermann, G. L., Nolan, CH. M.: Adrenocortical responsiveness after alternate-day corticosteroid therapy. New Engl. J. Med. 278, 405 (1968).

    Article  Google Scholar 

  • Albright, F., Henneman, P.H.: Suppression of Paget’s disease with ACTH and cortisone. Trans. Ass. Amer. Phycns 88, 238 (1955).

    Google Scholar 

  • Arnoldson, H.: Pituitary-adrenocortical function after multennial steroid therapy: significance of dosage and responsiveness to stress. In: An introduction to chnical neuroendocrinology, p. 201. Basle-New York: S. Karger 1967.

    Google Scholar 

  • Bacon, P. A., Myles,A.G., Blardwell, C. G., Daly,J.R.: Corticosteroid withdrawal in rheumatoid arthritis. Lancet 1966 II, 935.

    Google Scholar 

  • Begemann, H., Kaboth, W.: Nebenwirkungen der Cortison-derivate. Internist (Berl.) 8, 85 (1967).

    CAS  Google Scholar 

  • Bethge, H.: Die steroidinduzierte Nebennierenrindenunter-funktion. Pathogenese, Klinik, Diagnostik, Prophylaxe und Therapie. Khn. Wschr. 48, 317 (1970).

    Article  CAS  Google Scholar 

  • Boland, E. W.: Chnical comparison of the newer antiinflammatory corticosteroids. Ann. rheum. Dis. 21, 176 (1962).

    Article  PubMed  CAS  Google Scholar 

  • Brunner, K., Kaiser, G., Martz, G.: Die Corticosteroid-therapie der chronischen lymphatischen Leukämie. Dtsch. med. Wschr. 88, 1128 (1963).

    Article  CAS  Google Scholar 

  • Carreon, G.G., Canary, J.J., Meyer, R.J., Kyle., L.H.: Adrenocortical function after long-term corticoid therapy. J. Lab. Clin. Med. 56, 235 (1960).

    PubMed  CAS  Google Scholar 

  • Carter, M.E., James, V. H. T.: Pituitary-adrenal, response to surgical stress in patients receiving corticotrophin treatment. Lancet 1970 I, 328.

    Article  Google Scholar 

  • Dubois, E.L., Adler, D.C.: Single daily dose oral administration of corticosteroids in theumatic disorders: an analysis of its advantages, efficacy, and side effects. Curr. ther. Res. 5, 43 (1963).

    Google Scholar 

  • Editorial: The hypothalamic-pituitary axis. New Engl. J. Med. 279, 319 (1968).

    Google Scholar 

  • Eruhmann, G.: Cortisonderivate bei allergischen Krankheiten. Internist (Berl.) 8, 111 (1967).

    Google Scholar 

  • Graber, A. L., Ney, R.L., Nicholson, W. E., Island, D. P., Liddle, G.W.: Natural history of pituitary-adrenal recovery following long-term suppression with corticosteroids. J. Clin. Endocr. 25, 11 (1965).

    Article  PubMed  CAS  Google Scholar 

  • Grant, S.D., Forsham, P.H., Diraimondo, V.C.: Suppression of 17-hydroxycorticosteroids in plasma and urine by single and divided doses of triamcinolone. New Engl. J. Med. 273, 1115(1965).

    Google Scholar 

  • Harter, J.G., Reddy, W. J., Thorn, G. W.: Studies on intermittent corticosteroid dosage regimen. New Engl. J. Med. 269, 591 (1963).

    Article  PubMed  CAS  Google Scholar 

  • Hickler, R.B., Thompson, G.R, Fox,L.M., Hamlin, J.T.: Successful treatment of orthostatic hypotension with 9-a-Fluorohydrocortisone. New Engl. J. Med. 261, 788 (1959).

    Article  PubMed  CAS  Google Scholar 

  • Jasani,M.K., Boyle, J. A., Greig, W.R., Dalakos, T. G., Browning, M.C.K., Thompson, A., Buchanan, W.W.: Corticosteroid-induced suppression of the hypothalamo-pituitary-adrenal axis: observations on patients given oral corticosteroids for rheumatoid arthritis. Quat. J. med. 36, 261 (1967).

    CAS  Google Scholar 

  • Kaiser, H.: Cortisonderivate in Khnik und Praxis, 6. Aufl. Stuttgart: Thieme 1973.

    Google Scholar 

  • Kuemmerle, H. P., Senn, A., Rentchnick, P., Goossens, N.: Khnik und Therapie der Nebenwirkungen. Stuttgart: Thieme 1960.

    Google Scholar 

  • Kummer, D., Ochs, H.D.: Cytostatischer Wirkungsmechanismus von Cortisol und verwandten Steroiden. Z. ges. exp. Med. 147, 291 (1968).

    Article  CAS  Google Scholar 

  • Labhart, A.: Vermeidbare und nicht vermeidbare Schäden der Hormontherapie. Cortisonosteoporose und virilisierende Wirkung der anabolen Steroide. Schweiz, med. Wschr. 807 (1966).

    Google Scholar 

  • — Müller., J., Mayor, G.: Der chirurgische Eingriff unter hochdosierter Cortison-Therapie, bei Cushing-Syndrom und bei primärer oder sekundärer Nebennierenrindeninsuffizienz. In: Chirurgische Operationslehre. Founded by Breitner, Zukschwerdt und Kraus, Eds. Munich-Berlin-Vienna: Urban & Schwarzenberg 1969.

    Google Scholar 

  • Landolt,A.M., Siegfried,.: Zur Behandlung maligner, metastasierender Tumoren mit der stereotaktischen transsphenoidalen Elektrokoagulation der Hypophyse. Schweiz, med. Wschr. 100,1297 (1970).

    Google Scholar 

  • Legeler, H.J., Stoll, K.D.: Bericht über die klinische Prüfung von 9a-Fluorhydrocortison zur Behandlung hypotoner und orthostatischer Kreislaufregulationsstörungen. Arzneim.- Forsch. (Drug Res.) 21, 1144 (1971).

    Google Scholar 

  • Levell, M.J., Stitch, S.R., Noronha, M. J.: Impairment of the pituitary-adrenal axis following prolonged therapy with corticotrophin. Acta endocr. (Kbh.) 65, 608 (1970).

    CAS  Google Scholar 

  • Liddle, G.W., Fox, M.: Structure-function relationships of anti-inflammatory steroids. In: Inflammation and diseases of connective tissue: a Hahnemann symposium, L.C. Mills and J.H. Moyer, Eds. Philadelphia, London: Saunders 1961.

    Google Scholar 

  • Macgregor, R.R., Sheagren, J.N., Lipsett, M.B., Wolff, S.M.: Ahernate-day prednisone therapy. Evaluation of delayed hypersensitivity responses, control of disease and steroid side effects. New Engl. J. Med. 280, 1427 (1969).

    CAS  Google Scholar 

  • Magnenat,G., Cruchaud, S., Ruedi,B.: Incidences hypo-physo-serrénaliennes de la corticothérapie prolongée à faibles doses chez les asthmatiques. Schweiz. med. Wschr. 102, 804 (1972).

    PubMed  CAS  Google Scholar 

  • Malone, D.N.S., Grant, I.W.B., Percy-ROBB, I.W.: Hypo-thalamo-pituitary-adrenal function in asthmatic patients receiving long-term corticosteroid therapy. Lancet 1970 II, 733.

    Google Scholar 

  • Martin, M. M., Gaboardie, F., Podolski, S., Raiti, S., Calcagno, P.L.: Intermittent steroid therapy. Its effect on hypothalamic-pituitary-adrenal function and the response of plasma growth hormone and insuhn to stimulation. New Engl. J. Med. 279, 273 (1968).

    Article  PubMed  CAS  Google Scholar 

  • Nelson,J.K., Mackay,J.S., Sheridan,B., Weaver,.A.: Intermittent therapy with corticotrophin. Lancet 1966 II, 78.

    Article  Google Scholar 

  • Nichols, T., Nugent, C. A., Tyler, F.H.: Diurnal variation in suppression of adrenal function by glucocorticoids. J. clin. Endocr. 25, 343 (1965).

    Article  PubMed  CAS  Google Scholar 

  • Rappaport, E., Kuida, H., Dexter, L., Hennemann, Ph.H., Albright, F.: The cardiac output in Paget’s disease before and after treatment with cortisone. Amer. J. Med. 22, 252 (1957).

    Article  Google Scholar 

  • Thorn, G.W.: Clinical considerations in the use of corticosteroids. New Engl. J. Med. 274, 775 (1966).

    CAS  Google Scholar 

  • — Jenkins, D., Laidlaw, J. C., Goetz, F. C., Dingman, J.F., Arons, W. L., Streeten, D. H. O., Mccracken, B. H.: Pharmacological aspects of adrenocortical steriods and A.t. in man. New Engl. J. Med. 248,232,284, 323, 369, 414, 588, 632 (1953).

    Google Scholar 

  • V.r. ä N.e., K. O.: Cortisontherapie bei Auto-Immunkrankheiten. Internist (Berl.) 8, 94 (1967).

    Google Scholar 

  • Weissmann, G.: The effects of corticosteroids, especially on lysosomes and biomembranes. In: Rheumatoid arthritis; pathogenetic mechanisms and consequences in therapeutics, p. 577. W. Müller, H.-G. Harwerth, K. Fehr, Eds. London: Academic press 1971 (Colloquia Geigy).

    Google Scholar 

  • Wilbrandt, W.: Über die Wirkung von Corticosteroiden und anderen entzündungshemmenden Stoffen. Schwz. med. Wschr. 96, 1136(1966).

    Google Scholar 

Anabolic Steroids

  • Albright, F., Reifenstein, E.C., J.: Parathyroid glands and metabohc bone disease. Baltimore: Williams & Wilkins Co. 1948.

    Google Scholar 

  • Anderes, A.: Eine Übersicht über die therapeutisch verwendeten anabolen Steroide unter besonderer Berücksichtigung ihrer chemischen Struktur. Praxis 59, 650 (1970).

    PubMed  CAS  Google Scholar 

  • Bierich, J. R.: Die klinische Anwendung anabolischer Steroide. Mschr. Kinderheilk. 114, 444 (1966).

    PubMed  CAS  Google Scholar 

  • Breuer, H., K. ü Skemper, H. L., Bartsch, W.: Klinisch-experimentelle Untersuchungen mit eiweißanabol-wirk-samen 1-Methylandrostenolonen. Dtsch. med. Wschr. 87, 1349 (1962).

    Article  CAS  Google Scholar 

  • Damste, P.H.: Virilization of the voice due to anabohc steroids. Folia phoniat. (Basel) 16, 10 (1964).

    CAS  Google Scholar 

  • Edgren, R. A.: A comparative study of the anabohc and androgenic effects of various steroids. Acta endocr. (Kbh.) Suppl. 87 zu 44 (1963).

    Google Scholar 

  • Editorial: Androgenic and anabohc steroids. Brit. med. J. 1964 I, 165.

    Google Scholar 

  • Fruehan, A. E., Frawley, TH. F.: Current status of anabolic steroids. J. Amer. med. Ass. 184,527 (1963).

    Article  CAS  Google Scholar 

  • Gardner, F.H., Nathan, D.G.: Androgens and erythropoiesis. III. Further evaluation of testosterone treatment of myelofibrosis. New Engl. J. Med. 274,420 (1966).

    CAS  Google Scholar 

  • Gerber, M. W.: Zur Wirkung anaboler Hormone bei Azotä- mie. Helv. med. Acta 28, 197 (1961).

    CAS  Google Scholar 

  • Geyer, G., Jesserer, H.: Kann der gesteigerte Eiweiß- Katabohsmus während einer Cortisontherapie durch anabole Steroide ausgeglichen werden? 7. Symp. Dtsch. Ges. Endokr. Berlin-Göttingen-Heidelberg: Springer 1961.

    Google Scholar 

  • Holzknecht, F.: Gefahren der Therapie mit Anabólica. Med. Welt 39, 2238 (1965).

    Google Scholar 

  • Johnson, F. L., Feagler, J. R., Lerner, K., MAJERUS, P. W., Siegel, M., Hartmann, J.R., Thomas, E.D.: Association of androgenic-anabolic steroid therapy with development of hepatoceUular carcinoma. Lancet 1972 II, 1273.

    Article  Google Scholar 

  • Kory,R.C., Watson, R.N., Bradley, M. H., Peters, B.J.: A six month evaluation of an anabohc drug, norethandrolone, in chronically underweight individuals. J. clin. Invest. 36, 907 (1957).

    Google Scholar 

  • KüSkemper, H.L.: Anabole Steroide, 2. Aufl. Stuttgart: Thieme 1965.

    Google Scholar 

  • Labhart, A.: Vermeidbare und nicht vermeidbare Schäden der Hormontherapie. Cortisonosteoporose und virilisierende Wirkung der anabolen Steroide. Schweiz, med. Wschr. 96, 807 (1966).

    CAS  Google Scholar 

  • Marquardt, G. H., Fisher, C. I., Levy, P., Doroben, R. M.: Effects of anabolic steroids on liver function tests and creatine excretion. J. Amer. med. Ass. 175, 851 (1961).

    Article  CAS  Google Scholar 

  • The Medical Letter: The anabolic-androgenic steroids, vol. 3, 41 (1961).

    Google Scholar 

  • M ü L.e., A.: Médications anabolisantes et voix féminines. Pract. oto-rhino-laryng. (Basel) 26, 91 (1964).

    Google Scholar 

  • Nowakowski, H.: Klinische Indikationen der anabolen Steroide. Mkurse ärztl. Frtbild. 16, 229 (1966).

    Google Scholar 

  • Overbeek, G. A.: Anabole Steroide. Berhn-Heidelberg-New York: Springer 1966.

    Google Scholar 

  • Prader, A., Illig, R.: Use of anabolic agents in disorders of growth. In: Protein metabohsm, an international symposium. Berlin-Göttingen-Heidelberg: Springer 1962.

    Google Scholar 

  • — — Die Behandlung von Wachstumsstörungen mit anabolen Steroiden und mit Wachstumshormon. Dtsch. med. J. 13, 547 (1962).

    PubMed  CAS  Google Scholar 

  • Querido, A., Kassenaar, A. A.: Nitrogen retaining steroids and their application in disease. Advanc. Metabol. disorders. 2, 79 (1965).

    CAS  Google Scholar 

  • Reifenstein, E. C., Jr.: The rationale for the use of anabolic steroids in controlhng the adverse effects of corticoid hormones upon protein and osseous tissues. Sth. med. J. (Bgham, Ala.) 49, 933 (1956).

    Article  CAS  Google Scholar 

  • — Control of corticoid-induced protein depletion and osteoporosis by anabolic steroid therapy. Metabohsm 7, 78 (1958).

    Google Scholar 

  • Saarne, A., Bjerstaf, L., Ekman, B.: Studies on the nitrogen balance in the human during long-term treatment with different anabolic agents under strictly standardized conditions. Acta med. scand. 177, 199 (1965).

    Article  PubMed  CAS  Google Scholar 

  • Schaffner, F., Popper, H., Chesrow,E.: Cholestasis produced by the administration of Norethandrolone. Amer. J. Med. 26, 249 (1959).

    Article  PubMed  CAS  Google Scholar 

  • ScHÜPBACH, A.: Endokrines System und Skelett. Helvet. med. Acta 15, 537 (1948).

    Google Scholar 

  • Schwartz, W. B., Kassirer, J. P.: Medical management of chronic renal failure. Amer. J. Med. 44, 786 (1968).

    Article  PubMed  CAS  Google Scholar 

  • Watson, R.N., Bradley, M.H.>, Callahan, R., PETERS, B. J., K.r., R. S.: A six-month evaluation of an anabohc drug, norethandrolone, in underweight persons. Amer. J. Med. 26, 238 (1959).

    Article  PubMed  CAS  Google Scholar 

  • W.n., v., Landon, J., Kawerau, E.: Studies of hepatic function during methandienon therapy. Lancet 1961 I, 69.

    Google Scholar 

Progesterone in Respiratory Dysfunction

  • K ö Rting,G.W., Holzmann, H.: Gestagen-Behandlung der Sklerodermie. Aesthet. Med. 16, 10, 291 (1967).

    Google Scholar 

  • Lyons, H. A., Huang, C. T.: Therapeutic use of progesteron in alveolar hypoventilation associated with obesity. Amer. J. Med. 44, 1881 (1968).

    Article  Google Scholar 

  • Tyler, J. M.: The effect of progesteron on the respiration of patients with emphysema and hypercarbia. J. clin. Invest. 39, 34 (1960).

    Article  CAS  Google Scholar 

Glucagon in Heart Failure and Arrhythmias

  • Brogan,E., Kozonti, M. C., Overy, D.C.: Glucagon therapy in heart failure. Lancet 1969 I, 482.

    Article  Google Scholar 

  • Condon, J. R.: Glucagon in the treatment of Paget’s disease of bone. Brit. med. J. 1971 4, 719.

    Google Scholar 

  • Epstein, S. E., Skelton, C. L., Levey, G.S., Entman, M.: Adenyl cyclase and myocardial contractility. Ann. intern. Med. 72, 561 (1970).

    CAS  Google Scholar 

  • Greenberg, B. H., Tsakiris, A. G., Moffit, E.A., Frye, R.: Hemodynamics and metabohc effects of glucagon in patients with valvular heart disease. Amer. J. Cardiol. 23, 116(1969).

    Google Scholar 

  • Parmley, W. W.: The role of glucagon in cardiac therapy. New Engl. J. Med. 285, 801 (1971).

    Article  PubMed  CAS  Google Scholar 

  • — Glick, G., Sonnenblick, E. H.: Cardiovascular effects of glucagon in man. New Engl. J. Med. 279,11 (1968).

    Article  Google Scholar 

  • Ratti, R., Rothlin, M., Sennino, A.: Wirkung von Glukagon auf die Hämodynamik in der Frühphase nach Herzoperation. Schweiz, med. Wschr. 100, 2171 (1970).

    CAS  Google Scholar 

  • Robert, M., Humair, L.: Effet cardiotonique du glucagon. Etude clinique et indications thérapeutiques. Schwz. med. Wschr. 100, 1345 (1970).

    CAS  Google Scholar 

  • Simon, H., Esser, H., Fricke, G., Berchtold, P., Wardack, A., Franke, F.: Die Wirkung von Glukagon auf das insuffiziente Myokard. Verh. dtsch. Ges. inn. Med. 77, (1971).

    Google Scholar 

Download references

Authors
  1. A. Labhart
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. Martz
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 1974 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Labhart, A., Martz, G. (1974). Fundamentals of the Hormone Treatment of Nonendocrine Disorders. In: Clinical Endocrinology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-96158-8_20

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-96158-8_20

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-96160-1

  • Online ISBN: 978-3-642-96158-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation